evidence table

Bacopa Cognition Meta-Analysis Evidence Table

Structured evidence table for Bacopa Cognition Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Bacopa Cognition Meta-AnalysisBacopa consumption is known to enhance cognitive performance in healthy individuals and is associated with alterations in pathways related to branched-chain and aromatic amino acid biosynthesis.2Dwivedi A (2026)Efficacy of <i>Bacopa monnieri</i> (Linn.) on Cognitive Function and Alterations in Blood Metabolites in Patients With Amnestic Mild Cognitive Impairment and Early Alzheimer Disease: Protocol for an Exploratory Double-Blind, Randomized, Placebo-Controlled Trial.
Bacopa Cognition Meta-AnalysisThe cohort predominantly comprises men (53/60, 88.3%), individuals with at least a high school education (47/60, 78.3%), and participants at elevated risk for cognitive decline.2Dwivedi A (2026)Efficacy of <i>Bacopa monnieri</i> (Linn.) on Cognitive Function and Alterations in Blood Metabolites in Patients With Amnestic Mild Cognitive Impairment and Early Alzheimer Disease: Protocol for an Exploratory Double-Blind, Randomized, Placebo-Controlled Trial.
Bacopa Cognition Meta-AnalysisBackground Amnestic mild cognitive impairment (aMCI) represents a transitional stage between normal aging and Alzheimer disease (AD), where early intervention is critical for preserving cognition and delaying or preventing progression to dementia.2Dwivedi A (2026)Efficacy of <i>Bacopa monnieri</i> (Linn.) on Cognitive Function and Alterations in Blood Metabolites in Patients With Amnestic Mild Cognitive Impairment and Early Alzheimer Disease: Protocol for an Exploratory Double-Blind, Randomized, Placebo-Controlled Trial.
Bacopa Cognition Meta-AnalysisDue to the limited availability of curative pharmacological treatments, there is growing interest in traditional and indigenous medicinal interventions, such as Bacopa monnieri (Linn.) or Brahmi, a widely used Ayurvedic nootropic herb.2Dwivedi A (2026)Efficacy of <i>Bacopa monnieri</i> (Linn.) on Cognitive Function and Alterations in Blood Metabolites in Patients With Amnestic Mild Cognitive Impairment and Early Alzheimer Disease: Protocol for an Exploratory Double-Blind, Randomized, Placebo-Controlled Trial.
Bacopa Cognition Meta-AnalysisThis study consolidates the evidence based on phytochemicals for cognitive enhancement, highlighting a need for more robust, methodologically sound trials to determine if these natural compounds hold promise in cognitive therapeutics, particularly for populations with cognitive impairments.3Marsh Alexander (2026)The efficacy of nutritional phytochemical compounds in improving cognition
Bacopa Cognition Meta-AnalysisAccordingly, this review prespecified phytochemicals that meet 3 criteria: long-standing traditional association with cognition, biological plausibility supported by preclinical evidence, and progression into human research or commercial cognitive-health formulations, includingL.3Marsh Alexander (2026)The efficacy of nutritional phytochemical compounds in improving cognition
Bacopa Cognition Meta-AnalysisWhile the evidence surrounding green tea and its relevant constituents is relatively well summarized, the impact that other herbs and phytochemical compounds may have on cognition remains to be systematically reviewed.3Marsh Alexander (2026)The efficacy of nutritional phytochemical compounds in improving cognition
Bacopa Cognition Meta-Analysistenuiflorum This study addresses the effectiveness of various naturally occurring molecules in improving cognitive functions in healthy adults.3Marsh Alexander (2026)The efficacy of nutritional phytochemical compounds in improving cognition
topicBacopa Cognition Meta-Analysis
claimBacopa consumption is known to enhance cognitive performance in healthy individuals and is associated with alterations in pathways related to branched-chain and aromatic amino acid biosynthesis.
evidence level2
citationDwivedi A (2026)
sourceEfficacy of <i>Bacopa monnieri</i> (Linn.) on Cognitive Function and Alterations in Blood Metabolites in Patients With Amnestic Mild Cognitive Impairment and Early Alzheimer Disease: Protocol for an Exploratory Double-Blind, Randomized, Placebo-Controlled Trial.
topicBacopa Cognition Meta-Analysis
claimThe cohort predominantly comprises men (53/60, 88.3%), individuals with at least a high school education (47/60, 78.3%), and participants at elevated risk for cognitive decline.
evidence level2
citationDwivedi A (2026)
sourceEfficacy of <i>Bacopa monnieri</i> (Linn.) on Cognitive Function and Alterations in Blood Metabolites in Patients With Amnestic Mild Cognitive Impairment and Early Alzheimer Disease: Protocol for an Exploratory Double-Blind, Randomized, Placebo-Controlled Trial.
topicBacopa Cognition Meta-Analysis
claimBackground Amnestic mild cognitive impairment (aMCI) represents a transitional stage between normal aging and Alzheimer disease (AD), where early intervention is critical for preserving cognition and delaying or preventing progression to dementia.
evidence level2
citationDwivedi A (2026)
sourceEfficacy of <i>Bacopa monnieri</i> (Linn.) on Cognitive Function and Alterations in Blood Metabolites in Patients With Amnestic Mild Cognitive Impairment and Early Alzheimer Disease: Protocol for an Exploratory Double-Blind, Randomized, Placebo-Controlled Trial.
topicBacopa Cognition Meta-Analysis
claimDue to the limited availability of curative pharmacological treatments, there is growing interest in traditional and indigenous medicinal interventions, such as Bacopa monnieri (Linn.) or Brahmi, a widely used Ayurvedic nootropic herb.
evidence level2
citationDwivedi A (2026)
sourceEfficacy of <i>Bacopa monnieri</i> (Linn.) on Cognitive Function and Alterations in Blood Metabolites in Patients With Amnestic Mild Cognitive Impairment and Early Alzheimer Disease: Protocol for an Exploratory Double-Blind, Randomized, Placebo-Controlled Trial.
topicBacopa Cognition Meta-Analysis
claimThis study consolidates the evidence based on phytochemicals for cognitive enhancement, highlighting a need for more robust, methodologically sound trials to determine if these natural compounds hold promise in cognitive therapeutics, particularly for populations with cognitive impairments.
evidence level3
citationMarsh Alexander (2026)
sourceThe efficacy of nutritional phytochemical compounds in improving cognition
topicBacopa Cognition Meta-Analysis
claimAccordingly, this review prespecified phytochemicals that meet 3 criteria: long-standing traditional association with cognition, biological plausibility supported by preclinical evidence, and progression into human research or commercial cognitive-health formulations, includingL.
evidence level3
citationMarsh Alexander (2026)
sourceThe efficacy of nutritional phytochemical compounds in improving cognition
topicBacopa Cognition Meta-Analysis
claimWhile the evidence surrounding green tea and its relevant constituents is relatively well summarized, the impact that other herbs and phytochemical compounds may have on cognition remains to be systematically reviewed.
evidence level3
citationMarsh Alexander (2026)
sourceThe efficacy of nutritional phytochemical compounds in improving cognition
topicBacopa Cognition Meta-Analysis
claimtenuiflorum This study addresses the effectiveness of various naturally occurring molecules in improving cognitive functions in healthy adults.
evidence level3
citationMarsh Alexander (2026)
sourceThe efficacy of nutritional phytochemical compounds in improving cognition

Learn next

Related evidence and supplement guides

SupplementBerberinePlant alkaloid with clinical evidence rivalling metformin for blood glucose control and lipid ma...GuideNicotinamide Riboside Cognition Meta-analysis: What the Evidence SaysNicotinamide Riboside Cognition Meta-analysis has 2 source documents in the current Migaku evide...GuideAshwagandha Cognition Meta-analysis: What the Evidence SaysAshwagandha Cognition Meta-analysis has 2 source documents in the current Migaku evidence databa...GuideWalnut Cognition Meta-analysis: What the Evidence SaysWalnut Cognition Meta-analysis has 2 source documents in the current Migaku evidence database. T...GuideLuteolin Cognition Meta-analysis: What the Evidence SaysLuteolin Cognition Meta-analysis has 2 source documents in the current Migaku evidence database....RankingBest Nootropics for Focus & Attention: 2026 Clinical Evidence ReviewWe separate the clinical evidence from the marketing hype, ranking the most effective brain supp...RankingBest Supplements for Anxiety: Evidence-Based Rankings 2026Anxiety supplements with genuine clinical evidence include ashwagandha (strongest for chronic an...RankingBest Nootropics for Focus & Cognition: 2026 Clinical RankingsAn examination of cognitive enhancers designed to increase neurotransmitter activity, improve sy...

Source documents

  1. Efficacy of <i>Bacopa monnieri</i> (Linn.) on Cognitive Function and Alterations in Blood Metabolites in Patients With Amnestic Mild Cognitive Impairment and Early Alzheimer Disease: Protocol for an Exploratory Double-Blind, Randomized, Placebo-Controlled Trial.
  2. The efficacy of nutritional phytochemical compounds in improving cognition